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Synthesis and characterisation of bismacrocyclic
DO3A-amide derivatives – an approach towards
metal-responsive PARACEST agents†
Nevenka Cakić,a Tatjana Ž. Verbić,b Ratomir M. Jelić,c Carlos Platas-Iglesiasd and
Goran Angelovski*a
Three new bismacrocyclic Ln3+ chelates consisting of triamide derivatives of cyclen with glycine, methyl
and tert-butyl substituents (L1–3, respectively) linked to an acyclic EGTA-derived calcium chelator were
synthesised as potential MRI contrast agents (EGTA – ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-
tetraacetic acid). Eu3+ and Yb3+ complexes of L1–3 were investigated as chemical exchange saturation
transfer (CEST) agents. Moderate to minor CEST eﬀects were observed for Eu2L
1, Eu2L
2 and Yb2L
2 com-
plexes in the absence of Ca2+, with negligible changes upon addition of this metal ion. Luminescence
steady-state emission and lifetime experiments did not reveal any changes in the coordination environ-
ment of the complexes, while the number of inner-sphere water molecules remained constant in the
absence and presence of Ca2+. The protonation constants of Eu2L
1 and Eu2L
2 and stability constants of
their complexes with Ca2+, Mg2+ and Zn2+ were determined by means of potentiometric titrations. The
results show that the charge of the complex dramatically aﬀects the protonation constants of the EGTA-
binding unit. The stability constants of the complexes formed with Ca2+, Mg2+ and Zn2+ are several orders
of magnitude lower than those of EGTA. These ﬁndings indicate that the nature of Ln3+ chelates and their
charge are the main reasons for the observed results and weaker response of these EGTA-derived
triamide derivatives compared to their tricarboxylate analogues.
Introduction
The continuous development of contrast agents (CAs) for mag-
netic resonance imaging (MRI) has provided a wide range of
structurally diﬀerent compounds with a range of diagnostic
and therapeutic applications.1,2 The first generation and the
most widely used MRI contrast agents are based on paramag-
netic Gd3+ complexes or superparamagnetic iron–oxide nano-
particles (T1- and T2-shortening agents, respectively). Although
these CAs remain extensively investigated in basic research
and in clinical medicine, they exhibit certain limitations
related to their lack of tissue specificity and response to the
chemical environment. Therefore, alternative approaches for
producing image contrasts that provide additional information
are greatly appreciated, leading to the development of several
methodologies based on novel types of CAs.3 Among these, the
mechanism for altering MR contrast based on chemical
exchange saturation transfer (CEST) has been recently esta-
blished.4 This technique has been known and used in nuclear
magnetic resonance (NMR) for more than four decades,
however only lately has it attracted greater attention due to its
capability to generate an MRI contrast on its own, and also
due to its high sensitivity towards changes in the microenvir-
onment.5 CEST imaging requires suﬃciently slow exchange on
the magnetic resonance time scale to allow selective
irradiation of the protons of interest. The rate of exchange (kex)
that occurs between the two magnetically distinct environ-
ments must not be greater than the diﬀerence in frequency
between them (Δω), while several other physicochemical para-
meters can also aﬀect CEST MR contrast mechanisms, includ-
ing the relaxation rates of the two pools involved in chemical
exchange, temperature and concentration.6 Furthermore, a
methodology that exploits particular classes of paramagnetic
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lanthanide complexes for introducing tissue contrast via a
CEST mechanism has also been developed. These complexes
are specifically designed to shift exchangeable protons (–NH,
–OH, –SH or bound water) further away from the bulk water
allowing their distinct saturation, consequently reducing the
intensity of the bulk water MR signal and hence producing the
change in MRI contrast.7
The dependence of CEST contrast on diverse factors,
including those involving paramagnetic (PARACEST) agents,
can be used for the detection of specific biological processes
in tissues by means of MRI. Consequently, various molecular
imaging probes responsive to particular molecular events – the
so called bioresponsive or “smart contrast agents” (SCAs) –
have been designed.2 In most of the cases, MRI signal
changes are triggered by the variation in hydration number
or rotation dynamics for the T1- and T2-based CA. On the
other hand, signal diﬀerences produced by CEST agents are
caused by the exchange rate and the chemical shift of
the exchangeable proton pool, making CEST agents extremely
sensitive to environmental changes, and leading to the fast
development of responsive CEST agents. The most widely
investigated probes of this class show response to pH and
temperature, which allow a direct read-out of these relevant
physiological parameters in the disease state.8 However,
systems that provide responses to metabolites, biologically
relevant ions, enzyme or redox activity have also been
reported.6
The usage of SCAs in MRI for observing specific biological
processes is an extremely promising and potentially very bene-
ficial approach to study various functional processes at the
molecular and cellular level. For example, successful monitor-
ing of Ca2+ would be an extremely important step for the
understanding of basic physiological processes in the brain.
To date, there is a single report of PARACEST agents that
provide responses to this metal ion. The lanthanide ion chela-
tor consisted of the tetraamide derivative of cyclen and four
imino(diacetate) moieties that were envisaged to interact with
Ca2+. The corresponding Yb3+ and Eu3+ complexes were shown
to provide CEST responses to Ca2+; however, Mg2+ induced
similar CEST changes.9
On the other hand, excellent and selective responses to
Ca2+ were previously obtained for a series of GdDO3A-based
mono- and bismacrocyclic SCAs.10,11 In either of the cases, the
organic molecule was comprised of two diﬀerent moieties: a
cyclen-based ring(s) appended with acetate arms for Gd3+
chelation and an acyclic EGTA-derived part (EGTA – ethylene
glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid), as a
high aﬃnity and selective calcium chelator. The detailed
studies on these systems revealed that Ca-induced alteration of
the hydration number (q) was the major factor responsible for
the longitudinal relaxivity (r1) change.
10 The q alteration is the
direct consequence of the change in coordination of the car-
boxylate groups in the EGTA-derived chelator in the major
square antiprismatic (SAP) isomer, which flips from the Gd3+
coordination environment to Ca2+ upon its addition. Moreover,
the amide groups of the EGTA-derived chelator are also
expected to be in the vicinity of the lanthanide ion in the
presence or absence of Ca2+.11
Having these insights on the specific coordination aspects
that produce remarkable r1 changes on Gd-based Ca-respon-
sive SCAs, we sought to investigate their structural analogues
that could potentially serve as responsive PARACEST agents.
However, polyamino polycarboxylate DOTA/DO3A-type ligands
are not suitable for providing a CEST eﬀect due to the rapid
exchange of the coordinated water molecule, hence they
should be converted into slow-exchanging species.1 This can
be achieved by replacing the polyanionic arms of the ligand
with the neutral ones, thereby decreasing the water exchange
rate of the complex and making the agents suitable for
PARACEST.12,13 The most commonly investigated ligands for
this purpose are tetraamide derivatives of DOTA, especially
DOTAM-gly and its derivatives, although DO3A and DO2A
amide derivatives have also been reported.14 Thus, in an
attempt to prepare Ca2+ responsive PARACEST agents we
designed three diﬀerent bismacrocyclic ligands, each of them
bearing a standard EGTA-derived Ca-chelator coupled to
amide-type macrocyclic chelators for the complexation of
lanthanide metal ions. We varied the groups on the amide
moieties aiming to investigate the eﬀect of charge, hydropho-
bicity and steric hindrance. This resulted in the use of glycine,
methyl and tert-butyl substituents (L1–3, respectively) to replace
the six acetic moieties of the T1-responsive SCA (Chart 1).
Upon their synthesis, various physicochemical aspects were
investigated, including their CEST eﬀect, hydration number
assessment by means of time-resolved luminescence decay
measurements, NMR studies and estimations of stability con-
stants with endogenous metal ions by means of potentio-
metric titrations. CEST studies and luminescence lifetime
measurements in the presence of Ca2+ were also carried out to
assess the responsiveness of the synthesized agents to this
metal ion.
Results and discussion
Synthesis of the ligands
The desired ligands were prepared according to a convenient
six-step procedure (Scheme 1). The synthesis commenced from
the commercially available cyclen, which was monoalkylated
with benzyl(3-bromopropyl)carbamate 1 to give the building
block 2. The installation of diﬀerent amide substituents was
accomplished by alkylation of 2 with particular halogenides
Chart 1 Chemical structures of ligands L1–3 investigated in this work.
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3a–c in acetonitrile. The primary amines 5a–c were obtained
by reductive hydrogenation of 4a–c in ethanol using 10% Pd
on carbon as a catalyst. Further coupling of the obtained
amides 6a–c with amine 7 led to the protected bismacrocyclic
ligands 8a–c, which were treated with hydrochloric or formic
acid to aﬀord the desired ligands L1–3. Finally, bimetallic Eu3+
or Yb3+ complexes were prepared by mixing the ligands with
the corresponding LnCl3 salt while maintaining the pH value
between 6 and 7.
CEST properties
All the Z-spectra had been initially acquired at 25 °C with iden-
tical concentrations of the complexes (15 mM per Ln3+). Eu2L
1
exhibited a weak CEST eﬀect at 57 ppm, which is attributed to
the proton exchange between the Eu-bound and bulk water.
Temperature enhancement to 37 °C had a noticeable influence
on the CEST eﬀect resulting in an almost double increase in
intensity and an upfield shift of 3 ppm (Fig. 1a and b). Pre-
viously it was shown that PARACEST agents are more suitable
for noninvasive MRI thermometry methods than those
depending on T1 relaxation-time changes, chemical shift or
the diﬀusion coeﬃcient of bulk water. In the former case a
strong linear dependence of the chemical shift of the bound
water pool with temperature was observed (∼0.5 ppm °C−1),
while methods based on the determination of diﬀusion coeﬃ-
cients present low temperature sensitivity (∼0.01 ppm °C−1).15
The CEST eﬀect observed for Eu2L
1 is in good correlation with
these findings, showing a shift of 3 ppm for the increase in
temperature of 12 °C (∼0.25 ppm °C−1). However, the addition
of Ca2+ (up to 10 equiv.) did not provoke a marked change in
the CEST eﬀect at any of the investigated temperatures. This
result suggests that Ca2+ addition does not trigger important
changes in the coordination environment of the paramagnetic
Eu3+ centre, unlike the Gd-based Ca-sensitive systems contain-
ing acetate pendant arms.
The Z-spectra were also recorded using solutions of the
complexes with chelators L2–3, which possess a net positive
charge. For the ligand with N-methylamide groups, both Eu2L
2
and Yb2L
2 complexes showed a very weak CEST eﬀect upon sat-
uration of the resonances corresponding to the coordinated
water molecule (∼5% and 1% at 53 ppm and 230 ppm, respect-
ively). Similar to Eu2L
1, a very small quenching of the CEST
Scheme 1 Synthesis of the ligands L1–3. Reagents and conditions: (i) Et3N, CH2Cl2, RT, 59%. (ii) 3a–c, K2CO3, CH3CN, 70 °C, 66–83%. (iii) H2, Pd/C,
EtOH, RT, 92–96%. (iv) (ClCH2CO)2O, Et3N, CH3CN, RT, 74–82%. (v) K2CO3, KI, CH3CN, 70 °C, 67–79%. (vi) HCl or HCOOH, RT, 86–93%.
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signal was observed upon Ca2+ addition in both of these com-
plexes (Fig. 1c and d). Moreover, the Yb2L
2 complex provides a
weak CEST eﬀect at an oﬀset frequency of ∼−24 ppm that
remains nearly unaﬀected upon addition of Ca2+. This CEST
eﬀect is attributed to exchangeable NH protons, and is in
agreement with previous findings that revealed CEST peaks
due to amide protons in Yb3+ complexes in the range −15 to
−29 ppm.16–18 Finally, the Z-spectra of the complexes with
bulky tert-butyl substituents Eu2L
3 and Yb2L
3 did not show any
CEST eﬀect in the presence or absence of Ca2+ (data not
shown).
Apparently, the acquired Z-spectra and obtained CEST pro-
perties indicated that the prepared DO3A-amide Eu3+ and Yb3+
complexes likely have diﬀerent coordination characteristics
from their carboxylic Gd3+ analogues. The strongest CEST
signal was obtained for the DO3AM-gly-type derivative (Eu2L
1),
suggesting that the polarity of the side arms and the overall
charge of the complexes play important roles in determining
the exchange rate of the coordinated water molecule respon-
sible for the CEST signal. Previous reports showed that the
introduction of bulky groups into the amide side arms of
DOTAM derivatives accelerates water exchange in a favourable
way for the CEST eﬀect,19 although the opposite eﬀects were
also obtained.20 In this study the CEST eﬀect gradually
decreases on the DO3AM-type bismacrocyclic derivatives
towards the less polar and bulky substituents resulting in the
preferred order CH2COOH > CH3 > C(CH3)3. However, the
absence of any response to Ca2+ (its addition did not cause
observable reductions or increases in CEST eﬀects on Eu2L
1–2
or Yb2L
2) suggested that the coordination environment of the
paramagnetic ions in these triamide systems has been
changed compared to their tricarboxylic analogues, requiring
further investigation.
Luminescence experiments
The hydration states in the presence and absence of Ca2+ can
provide a good indication of potential changes in the environ-
ment of the paramagnetic ion upon Ca2+ addition. Thus, the
luminescence emission lifetimes of Eu2L
1–3 were recorded in
H2O and D2O, and the hydration numbers (q) were calculated
Fig. 1 The CEST spectra of 15 mM complexes (irradiation time 3 s, B1 = 25 μT) recorded in the absence (red) and presence (black) of 1 equiv. of Ca2+
for: (a) Eu2L
1, recorded at 25 and 37 °C, showing signals at 57 ppm and 54 ppm, respectively; (b) Eu2L
1 (magniﬁed CEST eﬀects, conditions provided
under (a); (c) Yb2L
2, insets show magniﬁed signals originating from bound water (230 ppm) and amide (∼−24 ppm) protons; (d) Eu2L2 the inset
shows the magniﬁed signal originating from bound water (53 ppm).
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according to a previously established methodology (Table 1).21
The obtained results show that the q number stays constant,
within the experimental error, upon calcium addition to all
the three investigated complexes. This behaviour is opposite
that of DO3A-based analogue SCA systems, which showed an
increase in the number of inner-sphere water molecules upon
Ca2+ addition.10,11 Further, the findings indicate that Eu2L
1
and Eu2L
3 are monohydrated complexes, while the less steri-
cally hindered complex Eu2L
2 displays an equilibrium between
dihydrated and monohydrated species. The absence of promi-
nent CEST eﬀects upon Ca2+ addition to aqueous solutions of
Eu2L
1–3 can certainly be correlated with hydration states
remaining constant, indicating that the addition of Ca2+ does
not provoke significant changes in the coordination environ-
ment of the lanthanide ion.
The luminescence steady-state emission spectra of Eu2L
1–3
in H2O were also recorded. Similarly to the decay experiments,
addition of Ca2+ did not produce any significant change in the
intensity or shape of the major 5D0 →
7F0–4 transitions (Fig. S1
in the ESI†). However, further splitting of the signals due to
the 5D0 →
7F1 and
5D0 →
7F4 transitions and change in the
intensity ratios of 5D0 →
7F1 and
5D0 →
7F2 transitions at 590
and 615 nm were observed at basic pH for Eu2L
1–2, suggesting
the change in polarisability of the axial donor and the local
symmetry at the metal centre (Fig. S2 in the ESI†). The major
cause for these spectral alterations was apparently a change in
protonation states of amines from the EGTA-derived chelator
and inner-sphere water molecules (see below).
NMR studies
The 1H NMR spectra of Eu2L
1–3 complexes were recorded in
D2O solutions at pD ∼ 8.0 (Fig. 2). They present relatively
broad resonances that spread over the range ∼−20 to 30 ppm
due to the paramagnetic shifts induced by the metal ion. The
spectrum of Eu2L
1 points to the presence of at least three
diﬀerent isomers in solution. It is well-known that DOTA-like
complexes may exist in solution as two diﬀerent isomers pro-
viding either a square-antiprismatic (SAP) or a twisted-square
antiprismatic (TSAP) coordination around the lanthanide(III)
ion. These isomers diﬀer either in the orientation of the
pendant arms of the macrocycle, which is often denoted as Δ
or Λ, or the conformation of the cyclen moiety [(δδδδ) or
(λλλλ)].22,23 In Eu3+ complexes of DOTA and DO3A derivatives
the signals of the pseudo-axial protons on the cyclen rings are
usually found between 24 and 45 ppm in the square antipris-
matic (SAP) isomer and below 25 ppm in the twisted-square
antiprismatic (TSAP) isomer.24–29 In the case of Eu2L
1, one of
the species present in solution shows signals in the range +15
to −20 ppm, while the second isomer with a smaller popu-
lation display signals due to the macrocyclic axial protons at
lower fields, one clearly visible at ∼19 and a broader one at
27 ppm. These results point to the presence of two nine co-
ordinate species with SAP and TSAP coordination around the
metal ion, the overall population being dominated by the TSAP
form (ca. 90%). This ratio of species is completely inverse to
that found for the responsive Gd-DO3A complexes where only
the SAP isomer changes its hydration upon binding with
Ca2+.11 Moreover, a third set of signals dominated by two reso-
nances at ca. 7.5–8.5 ppm is also observed. The spectrum of
Eu2L
2 is dominated by the latter signals, which on the basis of
the hydration number of this complex can be assigned to a
complex DO3A-type species containing two coordinated water
molecules. Similarly to Eu2L
1, the spectrum of Eu2L
3 displays
signals due to the monohydrated SAP and TSAP isomers, again
with the minor SAP isomer representing ca. 30% of the popu-
lation of the TSAP isomer. Additionally, the species attributed
to the bis-hydrated complex are also present, which is likely
the reason why luminescence lifetime measurements provide
hydration numbers slightly higher than one (Table 1).
Potentiometric titrations
To further characterize Eu2L
1–2 complexes, their protonation
constants, as well as stability constants of the complexes
formed with Ca2+, Mg2+ and Zn2+ were determined by means
of potentiometric titrations (Fig. S3 and S4 in the ESI†).
Complex formation of Eu–H–L1–2 systems. Binary complexes
formed in the studied aqueous solutions (t = 25 ± 1 °C, I =
0.1 M NaCl, pH range 4–10) were characterised using the
general equilibrium relation shown in eqn (1) (charges were
Table 1 Calculated q values for the Eu2L
1–3 with and without addition
of Ca2+
Complex
Without Ca2+ +Ca2+ (1 equiv.)
kH2O
(ms−1)
kD2O
(ms−1) q
kH2O
(ms−1)
kD2O
(ms−1) q
Eu2L
1 1.58 0.66 1.08 1.56 0.66 1.05
Eu2L
2 2.16 0.71 1.71 2.17 0.73 1.70
Eu2L
3 1.76 0.75 1.18 1.76 0.79 1.13
Fig. 2 1H NMR spectra of Eu2L
1–3 recorded in D2O solutions (pD ∼ 8.0,
25 °C). The asterisks indicate the most shifted resonances of axial
protons of the macrocycle in the SAP form. The insets show enhance-
ments of the 15–30 ppm regions obtained for Eu2L
1 and Eu2L
3.
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omitted for simplicity), and the corresponding cumulative
stability constants provided in eqn (2).
pEuþ qHþ rL ⇄ EupHqLr ; βp;q;r ðL ¼ L1 or L2Þ ð1Þ
βp;q;r ¼
½EupHqLr
½Eup½Hq½Lr ð2Þ
In order to study speciation in the three-component
systems Eu–H–L or Eu–OH–L (L = L1 or L2), it was necessary to
characterize the binary equilibria, i.e., hydrolysis of Eu3+ and
the ligands’ proteolytic equilibria. The equilibrium constants
of Eu3+ hydrolysis were taken from the literature,30 and the
ligand protonation constants calculated using the ADMET Pre-
dictor software31 (Table S1 in the ESI†), showing good agree-
ment with previously published values for DOTAM-type
systems.32 The equilibrium constants of the complexes were
determined using the Hyperquad 2008 software (using ionic
product value pKw = 13.77).
33 Species distribution diagrams
were plotted according to calculated constants using the HySS
software.34
The equilibrium constants of Eu–H–L complexes were
determined by acid–base potentiometric titrations (Tables 2
and S2 in the ESI†). Analysis of the potentiometric titration
data was performed to find the model that gives the best fit to
the experimental data (statistical parameters which determine
the quality of fit are provided in Table S2 in the ESI†). The cal-
culations revealed the formation of [Eu2(HnL)] (n = 1, 2, 3) as
well as [Eu2(L)] complexes. The formation of [Eu2L(OH)2] com-
plexes was also noticed. The obtained protonation constants
were compared to those previously published for ethylenedi-
aminetetraacetic acid (EDTA), EGTA and EGTA–bisamide
(Table 2),35 while the experimentally determined stability con-
stants with standard deviations are provided in the ESI
(Table S2†).
The first two protonation constants (log KH1 and log K
H
2 )
stand for protonation of the amine nitrogen atoms of the
EGTA-derived part. These values are quite diﬀerent for Eu2L
1
and Eu2L
2. The complex Eu2L
1 displays a higher basicity
similar to EDTA and especially EGTA; this can be explained by
the overall charge as the presence of six carboxylate groups on
the macrocycles in Eu2L
1 neutralize the positive charge of two
bound Eu3+ ions. This can also be the reason for the relatively
high log KH3 . On the other hand, the highly positively charged
Eu2L
2 behaves similar to the EGTA–bisamide, having one
neutral and one acidic amine nitrogen, respectively, and a
lower log KH3 value compared with Eu2L
1. Distribution dia-
grams of species in the Eu2L
1–2 system, for the concentration
ratio [L] : [Eu] = 1 : 2, indicate this diﬀerent behaviour (Fig. 3
and S5 in the ESI†). The dominating complex species at pH < 5
is [Eu2(H3L)], a complex in which Eu
3+ ions are coordinated to
the ligand L1 or L2 and the EGTA part is triprotonated. Conse-
quently, the species [Eu2(H3L
1)] and [Eu2(H3L
2)] have a
maximum concentration at pH 4.7 and 4.2, respectively. As pH
values increase, the [Eu2(H3L)] complex releases protons
forming [Eu2(H2L)], [Eu2(HL)], and [Eu2(L)], and finally the
[Eu2L(OH)2] complex. The complex [Eu2(L
1)] starts to form at
pH 7 and reaches the maximal concentration at pH 8.9 (Fig. 3),
while the complex [Eu2(L
2)] starts to form at pH 5 and reaches
the maximal concentration at pH 8.7 (Fig. S5 in the ESI†).
Moreover, the hydroxo complex [Eu2L(OH)2] in both cases
starts to form around pH 8, and reaches the maximum concen-
tration around pH 9.5. The hydroxide Eu(OH)3 begins to form
around pH 8.5, and its concentration increases with the
further increase of pH.
Complex formation of [Eu2L] with Ca
2+, Mg2+ or Zn2+;
heteronuclear systems. The stability constants for the complex
formation between Eu2L
1–2 and M (M = Ca2+, Mg2+ or Zn2+) are
represented using the general equilibrium relation shown in
eqn (3) (charges were omitted for simplicity), while the corres-
ponding cumulative stability constant is given by eqn (4).
pEuþ qHþ rLþmM ⇄ EupHqLrMm; βp;q;r;m ð3Þ
βp;q;r;m ¼
½EupHqLrMm
½Eup½Hq½Lr ½Mm ð4Þ
These stability constants were also determined by acid–base
potentiometric titrations. The obtained values were compared
with those previously reported for EDTA, 2,2′-oxybis-(ethyl-
Table 2 Experimentally determined protonation constants of Eu2L
1–2
complexesa compared to EDTA, EGTA and EGTA–bisamide protonation
constants reported in the literature
Eu2L
1 Eu2L
2 EDTAb EGTAb
EGTA–
bisamideb
log KH1 8.72 7.34 10.17 9.47 6.79
log KH2 8.29 5.20 6.11 8.85 5.87
log KH3 6.82 4.43 2.68 2.26 2.79
log KH4 — — 2.00 2.00
[Eu2(OH)2L] + 2H
+ ⇄
[Eu2L(H2O)2]
9.56 9.09
a I = 0.1 M (NaCl), t = 25 ± 1 °C. b I = 0.1 M (KCl), ref. 35.
Fig. 3 Distribution diagram of Eu3+–L1 species at [L] : [Eu] = 1 : 2 con-
centration ratio; total Eu3+ concentration 0.5 mM; I = 0.1 M (NaCl), t =
25 ± 1 °C.
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amine)-N,N,N′,N′-tetraacetic acid (OBETA) and EGTA
(Table 3),36–38 while the final set of complexes existing in the
studied aqueous solutions and experimentally determined
stability constants with standard deviations and statistical
parameters showing the quality of fit are provided in the ESI
(Table S3†). Finally, the corresponding distribution diagrams
of the species in the Eu3+–L–M systems (L = L1 or L2 and M =
Ca2+, Mg2+ or Zn2+) for the concentration ratio [Eu] : [L] : [M] =
2 : 1 : 1 are also plotted (Fig. 4 and S6–10 in the ESI†).
The stability constants obtained for Eu2L
1,2 with the investi-
gated metal ions were several orders of magnitude lower than
that for the well-studied EDTA, OBETA or EGTA chelators with
the same metals. There might be a few reasons for such behav-
iour. First, the binding aﬃnity of bisamide–bisacid chelators
(Eu2L
1,2) is expected to be weaker than in the case of tetraacid
chelators (EDTA, OBETA or EGTA) due to the reduction in the
number of negatively charged carboxylate chelating groups.
Next, the additional positive charge on the macrocyclic ring
(especially valid for Eu2L
2) induces the repulsion between the
Eu2L
1,2 complex and the positively charged metal complex.
This phenomenon can also be confirmed by the diﬀerences in
stability constants between Eu2L
1 and Eu2L
2, where the former
exhibits slightly higher values for all three metal ions due to
its lower net positive charge when compared to the latter
complex. Finally, the reduced flexibility of the EGTA-derived
chelator in Eu2L
1,2 due to the presence of bulky appended
macrocycles may prevent eﬃcient wrapping around the metal
ion compared with the case of flexible EDTA, OBETA or EGTA
chelators.
Furthermore, the obtained stability constants also indicate
a decrease in the selectivity of Eu2L
1,2 for Ca2+, Mg2+ and Zn2+.
This phenomenon can be easily followed by comparing
the ratio of stability constants for a single chelator with
two diﬀerent metals (Table 3). As it can be seen, the ratio of
log KEu2CaL/log KEu2MgL or log KEu2ZnL/log KEu2CaL for both
Eu2L
1,2 is comparable to analogous ratios obtained for EDTA
and OBETA despite much lower log KML values for Eu2L
1,2 and
the structural similarity of the chelating site to EGTA. This loss
of selectivity of Eu2L
1,2 for Ca2+ vs. Mg2+ could be explained by
the same reasons that lead to the drop in log KEu2ML values.
Namely, the reduced flexibility of Eu2L
1,2 compared to EGTA
prevents better recognition and size match of the EGTA-
derived chelator with Ca2+ than with Mg2+, while the increase
in the positive charge of Eu2L
1,2 additionally impairs binding
to metal ions and their recognition.
Despite the considerably lower stability constant values for
the three investigated metals, the distribution diagrams indi-
cate that heteronuclear complexes are the major species at the
physiological pH (Fig. 4 and S6–10 in the ESI†). The heteronuc-
lear complexes [Eu2(HnL
1)Ca] (n = 0, 1 or 2) are probably
formed by the following reaction:
½Eu2ðHnL1Þ þ Ca2þ ⇄ ½Eu2ðHnL1ÞCa; n ¼ 0; 1 or 2:
Consequently, the dominating complex at lower pH values
is [Eu2(H3L
1)], with a maximal concentration at pH around 4.5
(Fig. 4). Similar assumptions can be made according to the
obtained distribution diagrams of other heteronuclear com-
plexes, [Eu2(HnL
1)Mg] and [Eu2(HnL
1)Zn] (Fig. S6 and S7 in the
ESI†). The protonated heteronuclear complex, [Eu2(H2L
1)Ca]
has a maximum concentration at pH around 7 and is fairly
stable (Table S3 in the ESI†). The formation of the complex
[Eu2(HL
1)Ca] starts at around pH 6 and reaches the maximum
concentration at pH 8.2. The complex [Eu2(L
1)Ca] starts to
form at pH 7 and reaches the maximum concentration around
pH 9.
Conclusions
In this work we synthesised three diﬀerent bismacrocyclic
DO3A-amide derivatives appended with the EGTA-derived
chelator. The amides had glycine, methyl and tert-butyl as sub-
stituents resulting in ligands L1–3, respectively. The paramag-
netic complexes of L1–3 were prepared and various aspects of
their physicochemical behaviour were investigated. Eu2L
1
exhibited a greater CEST eﬀect than Eu2L
2 and Yb2L
2
Table 3 Experimentally determined stability constants of Eu3+–L–M
(L = L1 or L2; M = Ca2+, Mg2+ or Zn2+) complexesa compared to
Eu3+–L–M (L = EDTA, OBETA or EGTA; M = Ca2+, Mg2+ or Zn2+) stability
constants reported in the literature
L1 L2 EDTAb OBETAc EGTAb
Ca2+ 4.60 4.24 10.61 9.77 10.86
Mg2+ 4.08 3.38 8.69 7.95 5.28
Zn2+ 6.93 5.59 16.50 15.00 12.60
log KEu2CaL/log KEu2MgL log KCaL/log KMgL
1.13 1.25 1.22 1.23 2.06
log KEu2ZnL/log KEu2CaL log KZnL/log KCaL
1.51 1.32 1.56 1.54 1.16
a I = 0.1 M (NaCl), t = 25 ± 1 °C. b I = 0.1 M (KCl for EDTA, KNO3 for
EGTA), ref. 36 and 37. c I = 0.1 M (KNO3), ref. 38.
Fig. 4 Distribution diagram of Eu3+–L1–Ca species at [Eu] : [L1] : [Ca]
concentration ratio = 2 : 1 : 1; total Eu3+ concentration 0.5 mM; I = 0.1 M
(NaCl), t = 25 ± 1 °C.
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complexes, while Eu2L
3 and Yb2L
3 showed the absence of any
CEST eﬀect, suggesting that the polarity of substituents and
the overall charge of the complexes play an essential role in
the existence of the CEST eﬀect. Addition of Ca2+ led to negli-
gible changes in the CEST eﬀects in the investigated com-
plexes. The luminescence steady-state emission and lifetime
measurements confirmed the insensitivity of Eu2L
1–3 towards
Ca2+ as the inner-sphere hydration of the complexes remained
intact in the presence and absence of Ca2+. These findings
were in line with the results from 1H NMR experiments which
indicated the presence of diﬀerent mono- or bis-hydrated
isomers of Eu2L
1–3 in solution. However, the analysis of NMR
data revealed a switch of the SAP/TSAP isomer population for
DO3A-amide complexes when compared to the previously
investigated responsive Gd-DO3A complexes. In DO3A-amides,
the TSAP isomer appeared to be the major species, which does
not change the coordination environment around the Ln3+ ion
(i.e. inner-sphere hydration) upon complexation with Ca2+. It
has been shown that the population of the TSAP isomer
increases upon increasing the steric hindrance for the coordi-
nation of the pendant arms to the lanthanide(III) ion.39 Thus,
it is likely that the presence of the amide substituents in
Eu2L
1–3 introduces some steric hindrance that favors the TSAP
isomer over the SAP one. Finally, the results from potentio-
metric titrations showed a great dependence of protonation
constants on the net charge of the complexes Eu2L
1–2. They
bind Ca2+ with reduced aﬃnity and with a lower selectivity
towards Mg2+ or Zn2+ compared to the original EGTA chelator,
which is a consequence of their positive charge and reduced
flexibility of the binding site.
The results presented here suggest that replacement of
carboxylate for amide groups in macrocycles changes the
coordination to lanthanide metal ions and results in altera-
tions in their behaviour. Consequently, the interaction with
metal ions such as Ca2+ is dramatically aﬀected, converting the
Ca-sensitive DO3A-derived bioresponsive T1 agent into non-
sensitive DO3A-amide-derived potential CEST agents.
Obviously, further adjustments in the microenvironment
around the paramagnetic metal are required to obtain eﬃcient
CEST agents, prior or post interactions with the desired metal
ion. Thus, the present work provides an important set of infor-
mation that will aid better design of future bioresponsive
agents for CEST MRI.
Experimental section
General remarks
Commercially available reagents and solvents were used
without further purification. Compounds 1,40 3a,17 3b,41 3c19
and 7 10 were synthesised according to previously published
procedures. Purification of the synthesised compounds was
performed using silica gel 60 (0.03–0.2 mm) from Carl Roth
(Germany). Standard 0.1 M HCl and NaOH solutions were pre-
pared from ampoules (Titrisol, Merck, Darmstadt, Germany)
and potentiometrically standardised. Standard 5 mM Ca2+,
Mg2+, and Zn2+ solutions were prepared from appropriate salts
and standardised by titration with an EDTA solution. Acros
Organics buﬀers were used for electrode calibration (phthalate
pH 4.00, phosphate pH 7.00, and carbonate pH 10.00). All
NMR spectra were acquired on a Bruker Avance III 300 MHz,
processed using TopSpin 2.1 (Bruker GmbH), and analysed
with TopSpin 2.1 or ACD/SpecManager 9.0 (Advanced Chem-
istry Development, Inc.). The concentration of the complexes
was determined using the bulk magnetic susceptibility shift
(BMS).42 ESI-HRMS were performed on a Bruker BioApex II
ESI-FT-ICR, equipped with an Agilent ESI-Source, measured
via flow injection analysis. ESI-LRMS were performed on
an ion trap SL 1100 system (Agilent, Germany). Luminescence
lifetime measurements were performed by using a Quanta-
MasterTM 3-PH fluorescence spectrometer from Photon Tech-
nology International, Inc., (Monmouth Junction, NJ, USA).
Potentiometric titrations were performed by using a Metrohm
Basic Titrino 794 (Herisau, Switzerland) equipped with an
InLab Micro electrode (Mettler-Toledo International Inc.,
Columbus, Ohio, USA).
Synthetic procedures. Benzyl(3-(1,4,7,10-tetraazacyclododecan-
1-yl)propyl)carbamate (2)
Compound 2 was synthesised according to the previously
described procedure for monoalkylation of cyclen,43 using 1 as
the alkylating agent.
Compound 2: isolated yield: 59%. 1H NMR (CDCl3,
300 MHz), δ (ppm): 7.38–7.27 (m, 5H), 5.06 (s, 2H), 3.24–3.18
(br, 2H), 2.73–2.67 (br, 4H), 2.65–2.59 (br, 4H), 2.54–2.40 (br,
10H), 1.72–1.63 (m, 2H). 13C NMR (CDCl3, 75 MHz), δ (ppm):
156.6, 136.9, 128.3, 128.0, 127.8, 66.2, 52.1, 51.5, 47.0, 46.0,
45.1, 39.3, 27.5. ESI-HRMS: for C19H33N5O2
+: calc. 364.2707
[M + H]+, found 364.2711.
General procedure for the synthesis of 4a–4c
3a, 3b or 3c (3.2 equiv.) was added in an already prepared sus-
pension of 2 (1.0 equiv.) and K2CO3 (4.0 equiv.) in anhydrous
acetonitrile. The reaction mixture was stirred at 65 °C for 18 h.
After cooling, the product mixture was filtered and the solvent
was removed under reduced pressure. The residue was dis-
solved in dichloromethane and washed twice with water. The
organic layer was dried over Na2SO4 and then evaporated
under reduced pressure to give crude 4a, 4b or 4c. The com-
pounds were purified by column chromatography over silica
(eluent MeOH in CH2Cl2) to give 4a–c as amorphous solids.
Compound 4a. Starting from 3a (4.30 g, 20.7 mmol), 4.05 g
of 4a (66%) was obtained. The eluent for column chromato-
graphy purification was 7% MeOH in CH2Cl2.
1H NMR (CDCl3,
300 MHz), δ (ppm): 7.28–7.22 (m, 5H), 5.00 (s, 2H), 3.84–3.73
(br, 6H), 3.29–2.36 (br, 26H), 1.62–1.52 (m, 2H), 1.37–1.31
(overlapping s, 27H). 13C NMR (CDCl3, 75 MHz), δ (ppm):
172.2, 171.4, 169.1, 168.9, 168.8, 156.5, 136.9, 128.4, 128.1,
127.9, 81.8, 81.3, 66.2, 57.1, 56.8, 54.1, 53.5, 52.9, 51.1, 49.9,
41.9, 41.7, 38.9, 28.1, 27.9. ESI-HRMS: for C43H72N8O11
+: calc.
899.5213 [M + Na]+, found 899.5219.
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Compound 4b. Starting from 3b (5.00 g, 32.9 mmol), 4.40 g
of 4b (74%) was obtained. The eluent for column chromato-
graphy purification was 30% MeOH in CH2Cl2.
1H NMR
(CDCl3, 300 MHz), δ (ppm): 7.38–7.27 (m, 5H), 5.08 (s, 2H),
3.23–3.17 (m, 2H), 3.03 and 3.02 (overlapping s, 6H), 2.79–2.49
(br, 27H), 1.74–1.64 (m, 2H). 13C NMR (CDCl3, 75 MHz),
δ (ppm): 171.6, 171.3, 156.5, 136.5, 128.5, 128.2, 66.6, 59.1,
58.5, 54.0, 53.4 (br), 53.3 (br), 52.8, 39.6, 25.9, 25.8. ESI-HRMS:
for C28H48N8O5
+: calc. 577.3820 [M + H]+, found 577.3830.
Compound 4c. Starting from 3c (4.80 g, 24.7 mmol), 4.50 g
of 4c (83%) was obtained. The eluent for column chromato-
graphy purification was 10% MeOH in CH2Cl2.
1H NMR
(CDCl3, 300 MHz), δ (ppm): 7.28–7.25 (m, 5H), 5.0 (s, 2H),
3.52–2.65 (br, 26H), 1.85–1.61 (m, 2H), 1.29–1.27 (overlapping
s, 27H). 13C NMR (CDCl3, 75 MHz), δ (ppm): 168.6 (br), 168.0,
155.8, 135.7, 127.5, 127.0, 65.5, 56.8 (br), 52.5, 50.6 (br), 48.7
(br), 37.7, 27.7, 27.5 (br). ESI-LRMS: for C37H66N8O5
+: calc.
703.5 [M + H]+, found 703.5.
General procedure for the synthesis of 5a–5c
10% Pd/C was added to a solution of 4a (3.00 g, 3.4 mmol), 4b
(3.70 g, 6.4 mmol) or 4c (3.10 g, 4.4 mmol) in ethanol (50 mL).
The resulting mixture was stirred at room temperature under a
hydrogen atmosphere (3 bar) for 18 hours. The reaction was
then filtered over Celite® to remove the catalyst and the
solvent was removed by rotary evaporation. The residue was
dissolved in CH2Cl2 (50 mL) and the precipitate was removed
by filtration. The organic layer was dried over Na2SO4 and then
evaporated to give 5a (2.40 g, 94%), 5b (2.60 g, 92%) or 5c
(2.40 g, 96%).
Compound 5a. 1H NMR (CDCl3, 300 MHz), δ (ppm): 3.77
and 3.76 (overlapping s, 6H), 3.55–2.43 (br, 26H), 1.60–1.47
(m, 2H), 1.39–1.32 (overlapping s, 27H). 13C NMR (CDCl3,
75 MHz), δ (ppm): 173.1, 169.2, 168.5, 81.7, 81.5, 81.3, 58.4,
57.4 (br), 50.8 (br), 48.7, 42.1 (br), 41.9 (br), 40.0 (br), 28.1 (br),
28.0 (br). ESI-HRMS: for C35H66N8O9
+: calc. 743.5025 [M + H]+,
found 743.5030.
Compound 5b. 1H NMR (CD3OD, 300 MHz), δ (ppm):
3.38–3.05 (br, 8H), 2.79–2.45 (br, 27H), 1.85–1.70 (m, 2H).
13C NMR (CD3OD, 75 MHz), δ (ppm): 174.2, 173.4, 170.3, 59.8,
58.9, 52.2 (br), 51.9, 51.7, 40.4, 26.3 (br), 24.9. ESI-HRMS: for
C20H42N8O3
+: calc. 443.3453 [M + H]+, found 443.3458.
Compound 5c. 1H NMR (CDCl3, 300 MHz), δ (ppm):
3.61–2.40 (br, 26H), 1.94–1.55 (m, 2H), 1.38–1.34 (overlapping
s, 27H). 13C NMR (CDCl3, 75 MHz), δ (ppm): 171.2, 170.8,
169.9, 169.7, 66.4 (br), 58.0, 51.8, 51.7 (br), 51.6 (br), 51.5 (br),
50.7 (br), 28.8 (br), 28.5 (br). ESI-HRMS: for C29H60N8O3
+: calc.
569.4861 [M + H]+, found 569.4866.
General procedure for the synthesis of 6a–6c
5a, 5b or 5c (1 equiv.) and Et3N (1.5 equiv.) were dissolved in
anhydrous acetonitrile. The solution was cooled to 0 °C under
a nitrogen atmosphere and a solution of chloroacetic an-
hydride (1.3 equiv.) in acetonitrile was added dropwise. The
reaction was stirred at 0 °C for an additional 3 h. The solvent
was evaporated from the reaction mixture and the crude
product was purified by column chromatography over silica gel
(eluent MeOH in CH2Cl2) to give 6a, 6b or 6c.
Compound 6a. Starting from 5a (2.10 g, 2.8 mmol), 1.89 g
of 6a (82%) was obtained. The eluent for column chromato-
graphy purification was 10% MeOH in CH2Cl2.
1H NMR
(CDCl3, 300 MHz), δ (ppm): 4.00 (s, 2H), 3.82 (s br, 4H), 3.74
(s br, 2H), 3.34–2.22 (br, 26H), 1.68–1.58 (m, 2H), 1.38–1.32
(overlapping s, 27H). 13C NMR (CDCl3, 75 MHz), δ (ppm):
172.1, 168.9, 168.7, 166.4, 81.7, 81.4, 57.6, 56.9, 50.8 (br), 42.7,
41.7, 38.1, 29.6, 28.0, 24.6. ESI-HRMS: for C37H67ClN8O10
+:
calc. 841.4561 [M + Na]+, found 841.4562.
Compound 6b. Starting from 5b (2.30 g, 5.2 mmol), 2.20 g
of 6b (82%) was obtained. The eluent for column chromato-
graphy purification was 30% MeOH in CH2Cl2.
1H NMR
(CD3OD, 300 MHz), δ (ppm): 4.16 (s br, 2H), 3.80–3.20 (br,
22H), 3.08–2.98 (br, 4H), 2.84 and 2.82 (overlapping s, 9H),
2.09–2.01 (m, 2H). 13C NMR (CD3OD, 75 MHz), δ (ppm): 173.4
(br), 169.6, 166.2 (br), 57.6, 55.9, 53.7, 52.9 (br), 51.3 (br), 50.9
(br), 50.5, 43.5, 37.9, 37.1 (br), 36.2 (br), 26.8, 26.6, 23.8 (br).
ESI-HRMS: for C22H43ClN8O4
+: calc. 541.2988 [M + Na]+, found
541.2995.
Compound 6c. Starting from 5c (2.10 g, 3.7 mmol), 1.76 g of
6c (74%) was obtained. The eluent for column chromatography
purification was 30% MeOH in CH2Cl2.
1H NMR (CDCl3,
300 MHz), δ (ppm): 4.04 (s, 2H), 3.44–2.30 (br, 26H), 1.82–1.68
(m, 2H), 1.36–1.30 (overlapping s, 27H). 13C NMR (CDCl3,
75 MHz), δ (ppm): 171.8, 169.0, 52.1 (br), 51.7, 45.6, 43.9, 28.7
(br), 28.1 (br). ESI-LRMS: for C31H61ClN8O4
+: calc. 667.4
[M + Na]+, found 667.5.
General procedure for the synthesis of 8a–8c
The reaction flask was charged with 6a, 6b or 6c (1 equiv.), 7
(0.4 equiv.), K2CO3 (1.7 equiv.), KI (1 equiv.) and anhydrous
acetonitrile and the reaction mixture was heated at 70 °C over-
night under a nitrogen atmosphere. The inorganic salts were
removed by filtration and the solvent was evaporated to
dryness. The crude product was purified by column chromato-
graphy over silica gel using 8% MeOH in CH2Cl2 as the eluent
to give 8a, 8b or 8c.
Compound 8a. Starting from 6a (1.30 g, 1.6 mmol), 0.90 g
of 8a (70%) was obtained. 1H NMR (CDCl3, 300 MHz),
δ (ppm): 8.44 (s br, 3H), 7.93 (s br, 2H), 7.55 (s br, 3H), 3.76
and 3.75 (overlapping s, 12H), 3.69–3.53 (br, 12H), 3.43 (s, 4H),
3.33–3.20 (br, 14H), 2.91–2.30 (br, 42H), 1.58–1.55 (m, 4H),
1.38–1.34 (overlapping s, 72H). 13C NMR (CDCl3, 75 MHz),
δ (ppm): 172.6, 171.1 (br), 169.9, 168.9, 168.4, 82.4, 81.9, 81.6,
69.6, 68.4, 58.7 (br), 57.7 (br), 51.1 (br), 50.9 (br), 50.6, 50.3,
48.5, 41.8 (br), 41.7 (br), 39.9 (br), 29.6 (br), 27.9 (br), 23.8 (br).
Compound 8b. Starting from 6b (1.50 g, 2.9 mmol), 1.09 g
of 8b (67%) was obtained. 1H NMR (CD3OD, 300 MHz),
δ (ppm): 3.89–2.4 (br, 90H), 2.14–2.04 (m, 2H), 1.84–1.74 (m,
2H), 1.55–1.52 (overlapping s, 18H). 13C NMR (CD3OD,
75 MHz), δ (ppm): 175.1 (br), 174.5 (br), 174.0 (br), 173.5,
173.0, 168.8, 84.8, 82.9, 71.3, 71.1, 70.2, 67.9, 60.0, 58.6 (br),
58.1 (br), 56.0, 28.6, 28.5, 26.7, 26.5.
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Compound 8c. Starting from 6c (1.20 g, 1.9 mmol), 0.98 g of
8c (79%) was obtained. 1H NMR (CDCl3, 300 MHz), δ (ppm):
3.85–2.30 (br, 72H), 1.90–1.80 (m, 4H), 1.51–1.26 (overlapping
s, 72H). 13C NMR (CDCl3, 75 MHz), δ (ppm): 169.4, 166.5,
162.8, 80.8, 67.0, 53.4, 50.1 (br), 48.6, 48.2 (br), 46.9, 44.5, 26.9
(br), 26.7 (br), 26.6 (br), 26.1 (br).
General procedure for the synthesis of L1–3
Bismacrocycle 8a, 8b or 8c was dissolved in formic acid (3 mL)
and the solution was heated at 60 °C for 18 h (for potentio-
metric titrations, L1–2 were prepared by mixing 8a,b with 4 N
HCl (3 mL) in dioxane at RT for 4 hours). After the solution
was cooled, formic acid was removed on the rotary evaporator.
The residue was dissolved in a minimal amount of water,
added dropwise to cooled acetone (−20 °C) and stored in the
freezer overnight. The acetone was decanted from the solid
material and the crude products L1–3 were obtained by drying
in a vacuum.
Ligand L1. Starting from 8a (0.70 g, 0.4 mmol), 0.48 g of L1
(89%) was obtained. 1H NMR (D2O, 300 MHz), δ (ppm): 4.08 (s
br, 4H), 3.89–3.72 (br, 16H), 3.69 (s, 2H), 3.63–3.59 (br, 6H),
3.50–2.98 (br, 56H), 2.14–2.04 (m, 4H). 13C NMR (D2O,
75 MHz), δ (ppm): 175.62, 175.20, 172.11 (br), 171.03, 69.62,
65.51, 55.49, 55.17, 51.64 (br), 51.30, 49.03 (br), 46.75, 42.82,
36.59, 30.30, 21.37.
Ligand L2. Starting from 8b (0.45 g, 0.3 mmol), 0.38 g of L2
(93%) was obtained. 1H NMR (CD3OD, 300 MHz), δ (ppm):
3.74–3.20 (br, 52H), 3.03–2.69 (br, 38H), 2.00–1.90 (m, 4H).
13C NMR (CD3OD, 75 MHz), δ (ppm): 173.58, 171.00, 167.59,
71.33 (br), 71.19, 68.44, 67.32, 59.39, 59.13 (br), 57.99 (br),
56.48 (br), 54.47 (br), 53.26, 52.67 (br), 50.51 (br), 37.82 (br),
26.76, 26.50, 24.25 (br).
Ligand L3. Starting from 8c (0.66 g, 0.4 mmol), 0.53 g of L3
(86%) was obtained. 1H NMR (CD3OD, 300 MHz), δ (ppm):
3.95–2.61 (br, 72H), 1.92–1.80 (m, 4H), 1.26–1.13 (overlapping
s, 54H). 13C NMR (CD3OD, 75 MHz), δ (ppm): 171.10, 168.00,
166.41, 71.32, 67.16, 62.64, 55.77, 53.04 (br), 52.28 (br), 50.44
(br), 29.26 (br), 29.21 (br), 29.08.
General procedure for the preparation of Ln3+ complexes
The Ln3+ complexes of L2 and L3 were prepared by mixing the
respective ligand and the LnCl3 solutions in a 2 : 1 (Ln
3+ : L)
molar ratio. The exact amount of ligand was determined by
elemental analysis. The solution was stirred at RT for 48 h.
The pH value was adjusted to 7.0–7.5 using 1 M NaOH. The
absence of a free ion (Yb3+ or Eu3+) was verified by colorimetric
assay using xylenol orange.
In the case of negatively charged L1, EuCl3 was added in
slight excess (>2 equiv.). The mixture was stirred for 48 h at RT
maintaining the pH at 7.0–7.5, using 1 M NaOH. The resulting
solution was treated with Chelex 100 to remove the excess Eu3+
and the absence of free Eu3+ was verified by colorimetric assay
using xylenol orange.
Luminescence lifetime experiments
The lifetime measurements were performed on a Quanta-
MasterTM 3 PH fluorescence spectrometer from Photon Tech-
nology International, Inc. The measurements were performed
in H2O and D2O (25 °C) at 5 mM Eu
3+ concentration. The Eu3+
ion was directly excited at 395 nm, and the emission intensity
at 615 nm was measured with a 10 μs resolution. The exci-
tation and emission slits were set to 15 and 5 nm bandpass,
respectively. Data sets are an average of 25 scans, and each
reported value is the mean of three independent measure-
ments. The obtained curves are fitted to a first-order exponen-
tial decay with r2 = 0.99. The q values were calculated using
eqn (5).21
qEu ¼ 1:2 ½kH2O  kD2O  0:25þ 0:075nOvCHN; n ¼ 3 ð5Þ
Potentiometric titrations
Experiments were performed at t = 25 ± 1 °C, with a constant
argon flow, using a 794 Basic Titrino automatic titrator
(Metrohm, Herisau, Switzerland) equipped with an InLab
Micro electrode (Mettler-Toledo International Inc., Columbus,
Ohio, USA). The electrode–pH-meter system was calibrated by
means of a strong acid–strong base titration in 0.1 M NaCl,
using GLEE – GLass Electrode Evaluation software;44 standard
potential (E0 = 383.6 ± 0.2 mV) and slope (57.4 ± 0.1 mV) are
obtained as mean values of four titrations. Hyperquad 2008
software was used to calculate protonation and stability con-
stant values as the mean values of four titrations.33
Eu2L (L = L
1 or L2) protonation constant determination.
Eu2L complexes were previously synthesized in a solution. The
concentration of stock Eu2L solutions was determined accord-
ing to the BMS method.42 Stock Eu2L solutions were diluted
with 0.1 M NaCl to prepare working solutions ([Eu2L
1] = 2.4547
× 10−4 M, [Eu2L
2] = 4.9971 × 10−4 M). Prior to titration, stan-
dard HCl solution (0.0984 M; 35.0 µL for Eu2L
1, and 60.0 µL
for Eu2L
2) was added to 4.00 mL of Eu2L working solutions to
reach pH 4. All probes were titrated with 2.0 µL increments of
standard NaOH solution (0.1008 M) in the 4.0–10.0 pH range.
Eu2L (L = L
1 or L2) stability constants with Ca2+, Mg2+ and
Zn2+ determination. Prior to titration, standard HCl solution
(0.0984 M; 35.0 µL for Eu2L
1, and 60.0 µL for Eu2L
2) and
1.0–1.1, 1.2–1.3, and 1.5–1.6 mol-equivalents of standard Ca2+,
Mg2+, or Zn2+ solutions were added to 4.00 mL of Eu2L
working solutions and stirred for 10 minutes. All probes were
then titrated with 2.0 µL increments of standard NaOH solu-
tion (0.1008 M) in the 4.0–10.0 pH range. Total concentrations
of the ligand and metal ion used in each experiment are
provided in the ESI.†
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